Volume 10, Issue 3: Management of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome
eNeonatal Review is a monthly CE series for the NICU nurse and health care professional. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 10, Issue 3)
Target Audience
NICU nurses and health care professionals
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Discuss the current role of exogenous surfactant therapy in the treatment of respiratory distress syndrome.
- Identify current therapeutic strategies targeted at reducing the incidence of bronchopulmonary dysplasia.
- Evaluate the emerging evidence for stem cell therapies as applies to the prevention of bronchopulmonary dysplasia.
Bernard Thebaud, MD, PhD
Professor of Pediatrics
Children’s Hospital of Eastern Ontario
Ottawa, Ontario
Canada
Lannae Strueby, MD, FRCPC
Clinical Assistant Professor - Neonatology
Royal University Hospital
Saskatoon, Saskatchewan
Canada
Canada
Available Credit
- 1.00 ANCC
- 1.00 Attendance